Поговорим о рассеянном склерозе. Семь шагов к преодолению болезни

7. Miller, D.H., Hornabrook, R.W. & Purdie, G., ‘The natural history of multiple sclerosis: A regional study with some longitudinal data’, Journal of Neurology, Neurosurgery and Psychiatry, 1992, 55: 341–346.

8. Beiki, O., Frumento, P., Bottai, M., Manouchehrinia, A. & Hillert, J., ‘Changes in the risk of reaching multiple sclerosis disability milestones in recent decades: A nationwide population-based cohort study in Sweden’, JAMA Neurology, 2019; 76 (6): 665–671.

9. Jongen, P. J., Ter Horst, A. T. & Brands, A. M., ‘Cognitive impairment in multiple sclerosis’, Minerva Medica, 2012, 103 (2): 73–96.

10. Willis, S. N. & Stathopoulos, P., ‘Investigating the antigen specificity of multiple sclerosis central nervous system-derived immunoglobulins’, Frontiers in Immunology, 2015, 6: 600.

11. Frischer, J. M., Weigand, S. D., Guo, Y. et al., ‘Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque’, Annals of Neurology, 2015, 78 (5): 710–721.

12. Absinta, M., Lassmann, H. & Trapp, B. D., ‘Mechanisms underlying progression in multiple sclerosis’, Current Opinion in Neurology, 2020, 33 (3): 277–285.

13. Alcina, A., Abad-Grau, M. & Fedetz, M., ‘Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations’, PLoS One, 2012, 7 (1): e29819.

14. McDonnell, G. V., Mawhinney, H., Graham, C. A., Hawkins, S. A. & Middleton, D. ‘A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis’, Journal of the Neurological Sciences, 1999, 165 (1): 77–83.

15. Williams, A., Eldridge, R., McFarland, H., Houf,f S., Krebs, H. & McFarlin, D., ‘Multiple sclerosis in twins’, Neurology, 1980, 30 (11): 1139–1147.

16. Sladek, T., ‘The MS mystery in Syracuse: Why do we have highest rate of multiple sclerosis nationwide?’, 5 November 2019, CNY Central, https://cnycentral.com/news/local/the-ms-mystery-in-syracuse-why-do-we-have-highest-rate-of-multiple-sclerosis-nationwide, accessed July 2020.

17. Correa-D?az, E. P. & Ortiz, M. A., ‘Prevalence of multiple sclerosis in Cuenca, Ecuador’, Multiple Sclerosis Journal – Experimental, transnational and clinical, 2019, 5 (4).

18. Zambrano, A. K. & Gaviria, A., ‘The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome data’, Scientific Reports, 2019, 9, 9247.

19. Langer-Gould, A., Brara, S. M., Beaber, B. E. & Zhang, J. L., ‘Incidence of multiple sclerosis in multiple racial and ethnic groups’, Neurology, 2013, 80 (19): 1734–1739.

20. Smatti, M. K., Al-Sadeq, D. W. & Ali, N. H. et al., ‘Epstein-Barr Virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: An update’, Frontiers in Oncology, 13 June 2018.

21. Guan, Y., Jakimovski, D., Ramanathan, M. et al., ‘The role of Epstein-Barr virus in multiple sclerosis: From molecular pathophysiology to in vivo imaging’, Neural Regeneration Research